Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Spiera

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2017
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu ArteritisCarol A Langford, David Cuthbertson, Steven R Ytterberg, et al.
Arthritis and Rheumatism|September 29, 2011
Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitisPaul A Monach, Gunnar Tomasson, Ulrich Specks, et al.
Annals of the Rheumatic Diseases|September 15, 2012
Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitisPaul A Monach, Roscoe L Warner, Gunnar Tomasson, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitisJohn H Stone, Peter A Merkel, Robert Spiera, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2025
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitisCarol A Langford, Nader Khalidi, Jason Springer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2023
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic SclerosisRobert Spiera, Masataka Kuwana, Dinesh Khanna, et al.
The New England Journal of Medicine|August 2, 2013
Efficacy of remission-induction regimens for ANCA-associated vasculitisUlrich Specks, Peter A Merkel, Philip Seo, et al.
Annals of the Rheumatic Diseases|September 12, 2015
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiativeChristian Dejaco, Yogesh P Singh, Pablo Perel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2015
2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiativeChristian Dejaco, Yogesh P Singh, Pablo Perel, et al.
Rheumatology (Oxford, England)|June 6, 2018
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohortsDane H Dougherty, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2017
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu ArteritisCarol A Langford, David Cuthbertson, Steven R Ytterberg, et al.
Arthritis and Rheumatism|September 29, 2011
Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitisPaul A Monach, Gunnar Tomasson, Ulrich Specks, et al.
Annals of the Rheumatic Diseases|September 15, 2012
Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitisPaul A Monach, Roscoe L Warner, Gunnar Tomasson, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitisJohn H Stone, Peter A Merkel, Robert Spiera, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2025
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitisCarol A Langford, Nader Khalidi, Jason Springer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2023
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic SclerosisRobert Spiera, Masataka Kuwana, Dinesh Khanna, et al.
The New England Journal of Medicine|August 2, 2013
Efficacy of remission-induction regimens for ANCA-associated vasculitisUlrich Specks, Peter A Merkel, Philip Seo, et al.
Annals of the Rheumatic Diseases|September 12, 2015
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiativeChristian Dejaco, Yogesh P Singh, Pablo Perel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2015
2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiativeChristian Dejaco, Yogesh P Singh, Pablo Perel, et al.
Rheumatology (Oxford, England)|June 6, 2018
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohortsDane H Dougherty, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Pageof 10